PSK1 COST-EFFECTIVENESS ANALYSIS OF AMEVIVE TM (ALEFACEPT) IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62865-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)62865-3/fulltext
Section Title :
Section Order :
302
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62865-3&doi=10.1016/S1098-3015(10)62865-3